618 Results for "

allosteric modulator

" in MedChemExpress (MCE) Product Catalog:
Products (618)

618 Results for "allosteric modulator" in MCE Product Catalog:

27
27 Publications Verification
Cat. No.: HY-100403
CAS No.: 298690-60-5
Purity:  99.67%
Target:  

mGluR

Research Areas:  

Cancer

Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM . Ro 67-7476 is a potent P-ERK1/2 agonist and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM) .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-A0106
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole
Target:  

nAChR Parasite

Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-17537
CAS No.: 1216665-49-4
Target:  

IRE1

Research Areas:  

Cancer

APY29, an ATP-competitive inhibitor, is an allosteric modulator of IRE1α which inhibits IRE1α autophosphorylation by binding to the ATP-binding pocket with IC50 of 280 nM. APY29 acts as a ligand that allosterically activates IRE1α adjacent RNase domain .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10167A
CAS No.: 177172-49-5
Purity:  99.66%
Synonyms: R-568 hydrochloride; NPS R-568
Target:  

CaSR

Research Areas:  

Others

Tecalcet Hydrochloride (R 568 Hydrochloride), an orally active calcimimetic compound, allosterically and positively modulates the calcium-sensing receptor (CaSR). Tecalcet Hydrochloride (R 568 Hydrochloride) increases the sensitivity to activation by extracellular Ca 2+ .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P1125
CAS No.: 300851-67-6
Research Areas:  

Others

4-CMTB is a selective free fatty acid receptor 2 (FFA2/GPR43) agonist and a positive allosteric modulator (pEC50=6.38) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-103320A
CAS No.: 2387505-78-2
Purity:  99.81%
Target:  

CaSR

Research Areas:  

Metabolic Disease

Calhex 231 hydrochloride is a potent negative allosteric modulator that blocks (IC50 = 0.39 μM) increases in [ 3H]inositol phosphates elicited by activating the human wild-type CaSR transiently Ca 2+-sensing receptor. Calhex 231 hydrochloride can be used in the study of traumatic hemorrhagic shock (THS) and diabetic cardiomyopathy (DCM) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112209
CAS No.: 1451993-15-9
Purity:  99.24%
Target:  

mAChR

Research Areas:  

Neurological Disease

VU0467154 is a positive allosteric modulator of the M4 muscarinic acetylcholine receptor (mAChR), potentiating the response to ACh with pEC50s of 7.75, 6.2 and 6 for rat, human and cynomolgus monkey M4 receptor, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-124634
CAS No.: 2170608-82-7
Purity:  99.68%
Target:  

PANK

Research Areas:  

Neurological Disease

PZ-2891 is an orally bioavailable, brain penetrant pantothenate kinase (PANK) modulator. PZ-2891 act as an orthosteric inhibitor at high concentrations and an allosteric activator at lower sub-saturating concentrations. PZ-2891 inhibits human pantothenate kinases PANK1β, PANK2, and PANK3 with IC50s of 40.2 nM, 0.7 nM and 1.3 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N2370
CAS No.: 30271-38-6
Category:  

Animals Steroids

Target:  

iGluR LXR

24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16579
CAS No.: 56776-32-0
Synonyms: HOE 36-801 hydrochloride
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine hydrochloride, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine hydrochloride reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16579A
CAS No.: 21715-46-8
Synonyms: HOE 36-801
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-128770
CAS No.: 1638667-79-4
Purity:  98.06%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124419
CAS No.: 714971-87-6
Purity:  98.42%
Target:  

mGluR

Research Areas:  

Neurological Disease

RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10933
CAS No.: 154235-83-3
Purity:  99.94%
Synonyms: BDP 12
Target:  

iGluR

Research Areas:  

Neurological Disease

CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120023
CAS No.: 1432436-13-9
Purity:  99.67%
Target:  

mAChR

Research Areas:  

Neurological Disease

VU0453595 is a highly selective, systemically active M1 positive allosteric modulator (PAM, EC50=2140 nM) for the research of schizophrenia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108710
CAS No.: 1809085-30-0
Purity:  99.55%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM. VU0650786 has antidepressant and anxiolytic activity in rodents .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109160
CAS No.: 2167246-24-2
Purity:  99.27%
Synonyms: CAD-1883
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134494
CAS No.: 2375070-79-2
Purity:  99.90%
Target:  

GPR68

Research Areas:  

Neurological Disease

MS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). MS48107 is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. MS48107 can readily cross the blood-brain barrier (BBB) in mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103524
CAS No.: 3569-10-6
Purity:  ≥99.0%
Synonyms: (-)-Valerenic Acid
Research Areas:  

Neurological Disease

Valerenic acid ((-)-Valerenic Acid), a sesquiterpenoid, is an orally active positive allosteric modulator of GABAA receptors. Valerenic acid is also a partial agonist of the 5-HT5a receptor. Valerenic acid mediates anxiolytic activity via GABAA receptors containing the β3 subunit. Valerenic acid also exhibits potent antioxidant properties .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12150
CAS No.: 917837-54-8
Purity:  99.97%
Synonyms: AVL-3288; UCI-4083
Target:  

nAChR

Research Areas:  

Neurological Disease

CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction .
loading...
    loading...